Home » Topics » Regulatory » Patents

Patents
RSS

Shanghai Fochon Pharmaceutical describes CDK4/cyclin D1 and CDK6/cyclin D1 inhibitors

Nov. 21, 2016

University of North Carolina at Chapel Hill discloses anticancer agents

Nov. 21, 2016

Omeros patents PDE10A inhibitors

Nov. 21, 2016

Sanford-Burnham Medical Research Institute presents EphA4 inhibitors

Nov. 18, 2016

Chinese researchers develop antiviral agents

Nov. 18, 2016

Janssen Pharmaceutica discloses TARPgamma8 modulators

Nov. 18, 2016

Eli Lilly and Company describes BACE1 inhibitors

Nov. 18, 2016

Sanford-Burnham Medical Research Institute patents APJ agonists

Nov. 18, 2016

Chinese scientists present FXR agonists

Nov. 17, 2016

Japanese researchers develop antimalarial agents

Nov. 17, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026